a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Smiles: CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N2)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(N)=O)[C@@H](C)O
is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) on the outer face of the inner mitochondrial membrane
c-di-AMP sodium combines with model antigens
m-PEG2-phosphonic acid Catalog No.:M15137-2 a new S-adenosylmethionine decarboxylase inhibitorm PEG2 phosphonic acid is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 96962 41 3 Molecular Weight: 184. 13 Formula: C5H13O5P Chemical Name: [2 (2 methoxyethoxy)ethyl]phosphonic acid Smiles: COCCOCCP(O)(O)=O InChiKey: PCGVEHCDYPVDET UHFFFAOYSA N InChi: InChI=1S C5H13O5P c1 9 2 3 10 4 5 11(6,7)8 h2 5H2,1H3,(H2,6,7,8) Technical Data Appearance: Solid Power Purity: 98% (or refer to the